EkoSonicTM Endovascular System

DEVICE2 trials

Sponsors

Boston Scientific Corporation

Conditions

Acute Pulmonary EmbolismPulmonary Embolism

Phase 4

Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism

Active, not recruitingNCT04790370

Boston Scientific CorporationPulmonary Embolism

Start: 2021-08-02End: 2026-08-01Updated: 2026-07-01

Unknown Phase

A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism

RecruitingNCT06819865

Boston Scientific CorporationAcute Pulmonary Embolism

Start: 2026-08-30End: 2029-05-30Target: 30Updated: 2026-08-17

Related Papers

Clinical Outcomes in Patients With Acute Pulmonary Embolism Undergoing Ultrasound‐Assisted Catheter‐Directed Thrombolysis

Journal of the American Heart Association2025-04-264 citations

Prospective Multicenter International Registry of Ultrasound-Facilitated Catheter-Directed Thrombolysis in Intermediate-High and High-Risk Pulmonary Embolism (KNOCOUT PE)

Circulation Cardiovascular Interventions2024-01-2438 citations

Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study.

2022-05-16128 citations